ABSTRACT
The interaction between Mycobacterium tuberculosis, the agent of tuberculosis (TB), and its host cell, the macrophage, is multifaceted, dynamic, and involves multiple molecular partners. A better understanding of this interaction could help researchers manipulate the immune system in order to design host-targeted immunotherapies and/or develop a novel vaccine protecting better adults against TB. Jani and coworkers studied the role of the macrophage receptor TLR2 in the response to M. tuberculosis using single-cell technologies (C. Jani, S. L. Solomon, J. M. Peters, and S. C. Pringle, et al., mSystems, https://doi.org/10.1128/msystems.00052-23, 2023). This work addresses the multiple challenges associated with such studies and shows how informative single-cell analysis can be for the study of heterogeneous and complex host-pathogen interactions.
KEYWORDS: Mycobacterium tuberculosis, macrophage, TLR2, single-cell RNA sequencing
COMMENTARY
Pathogen recognition is a key component of innate immunity, which informs of the nature of the pathogen encountered and allows its early clearance. Pathogen recognition is also an essential step toward the mounting of a more specific host response, the so-called adaptive immune response, that is necessary for eliminating recalcitrant pathogens (1, 2).
Host cells recognize bacterial pathogens with pattern-recognition receptors (PRRs) of different nature and localization. Among PRRs, Toll-like receptors (TLRs) were the first identified and are the best characterized so far (3). TLRs are transmembrane proteins localized either at the cell surface or within intracellular vesicles that recognize pathogen-associated molecular patterns (PAMPs), either secreted or present at the surface of the microbes. TLRs allow the recognition of a wide variety of PAMPs in the form of nucleic acids, proteins, and lipids (2, 4, 5). PAMPs are often invariable structures whose expression is vital to the bacteria, such as the lipopolysaccharide for Gram-negative bacteria, teichoic acid for Gram-positive bacteria, or the widespread peptidoglycan polymer (4).
Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis (TB), is a pathogen extensively studied for its interaction with its human host as being the first human killer among bacterial pathogens (WHO, Global TB Report 2022). TB affects mainly the lungs, where the bacteria interact with a variety of immune and non-immune cells. Among those cells, the study of macrophages is taking the most attention, as this cell type is the primary site of Mtb recognition, replication, and containment (6 – 8).
Mtb PAMPs are recognized by macrophages with TLRs such as TLR4 and TLR2 (9, 10). Jani et al. compared the early transcriptional response of macrophages to Mtb PAMPs and live Mtb and focused on the role of TLR2 in this process (11). PAMPs tested were lipids of various nature, including pthiocerol dimycocerosate, trehalose dimycolate, sulfolipid-1, mannose-capped-lipoarabinomannan, and phosphatidylinositol mannoside 6 (PIM6), as well as a total cell wall extract of Mtb. This study confirmed that Mtb elicits mainly two types of responses in macrophages, namely the NF-κB and the type I IFN-dependent signaling pathways. The authors found that the type I IFN response is mainly activated in response to live Mtb. This observation agrees with previous work showing that the induction of the type I IFN response in macrophages requires the presence of live mycobacteria expressing an intact type VII secretion system (ESX-1) (12 – 15).
On the other hand, the NF-κB response was stimulated by both live Mtb and PAMPs. Interestingly, the NF-κB response was weaker for live and dead Mtb in comparison to isolated PAMPs. The authors conclude that this difference in NF-κB induction levels between whole Mtb bacilli and isolated PAMPs might rely on the differences in antigen recognition of isolated PAMPs versus PAMPs included in the Mtb cell wall. In addition to this difference in antigen recognition, it is possible that PAMPs present at the surface of Mtb dampen the NF-κB response triggered by other PAMPs, as previously demonstrated for sulfoglycolipids antagonizing Mtb PAMPs recognition by TLR2 (16). Interestingly, Mtb-infected macrophages and bystander macrophages (non-infected macrophages) show overall a similar transcriptional response, reflecting some level of communication between infected and non-infected cells and/or the activity of Mtb-secreted PAMPs and/or PAMPs-containing exosomes on noninfected cells (17).
The authors show that in murine macrophages, the NF-κB response to PIM6 is uniquely dependent upon TLR2 and that PIM6/TLR2 interaction makes a unique contribution to the macrophage response to Mtb. The authors also show that the earliest TLR2-dependent transcriptional responses observed in in vitro cultivated macrophages are conserved in vivo and that a lack of TLR2 in mice impacts the quantity and phenotype of cellular subsets that emerge post-infection.
In apparent contradiction with the important role of TLR2 in Mtb recognition, the authors show that mice lacking TLR2 are as susceptible to TB as wild-type mice at 6 wk post-infection. This observation agrees with previous studies and emphasizes the controversial role of TLR2 in TB protection in mice (18 – 21). Differences in the genetic background of the mice and the bacteria used, as well as of the infection protocol employed, could be the cause of the discrepant results observed regarding the role of TLR2 in the protection against TB in mice. Moreover, TLR2 activation itself was shown to have both a positive and a negative impact on the control of Mtb infection, which might add to the complexity of the interpretation of the results (9, 22 – 24).
Importantly, many studies have shown that TLR2 has a protective role against TB in humans, as specific polymorphisms in the TLR2 gene are associated with a higher risk of developing TB (25 – 28). The dissimilar role of TLR2 in the protection against TB in human and mice could originate from the difference(s) in the nature of the TLR2-dependent response(s) in those organisms. For example, an antimicrobial TLR2-dependent and vitamin D-mediated innate immune response is present in humans but absent in mice (29).
Altogether, the authors highlight the complexity and heterogeneity of the macrophage response to Mtb infection. Other factors, such as the variability in the genetic background of the host and the bacteria (30), the origin, and status of the infected macrophages (31) as well as the phenotype of the ingested bacteria (32), might influence the outcome of such interactions and increase the complexity of their study. To tackle those challenges, this work, among others, advocates for the use of single-cell technologies, including single-cell RNA sequencing and Flow Fluorescent In Situ Hybridization, to allow in-depth and unbiased profiling of immune cell populations and study the fate of individual bacteria in isolated immune cells (33 – 35).
ACKNOWLEDGMENTS
I thank Pr. Sabine Ehrt for reading the manuscript and helpful comments.
The views expressed in this article do not necessarily reflect the views of the journal or of ASM.
Contributor Information
Alexandre Gouzy, Email: alg2053@med.cornell.edu.
Jack A. Gilbert, University of California San Diego, La Jolla, California, USA
REFERENCES
- 1. Medzhitov R, Janeway CA. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295–298. doi: 10.1016/s0092-8674(00)80412-2 [DOI] [PubMed] [Google Scholar]
- 2. Creagh EM, O’Neill LAJ. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27:352–357. doi: 10.1016/j.it.2006.06.003 [DOI] [PubMed] [Google Scholar]
- 3. Fitzgerald KA, Kagan JC. 2020. Toll-like receptors and the control of immunity. Cell 180:1044–1066. doi: 10.1016/j.cell.2020.02.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–650. doi: 10.1016/j.immuni.2011.05.006 [DOI] [PubMed] [Google Scholar]
- 5. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11:373–384. doi: 10.1038/ni.1863 [DOI] [PubMed] [Google Scholar]
- 6. Guirado E, Schlesinger LS, Kaplan G. 2013. Macrophages in tuberculosis: friend or foe. Semin Immunopathol 35:563–583. doi: 10.1007/s00281-013-0388-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Huang L, Nazarova EV, Russell DG. 2019. Mycobacterium tuberculosis: bacterial fitness within the host macrophage. Microbiol Spectr 7. doi: 10.1128/microbiolspec.BAI-0001-2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile J-F, Marchou B, Cardona P-J, de Chastellier C, Altare F. 2008. Foamy Macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4:e1000204. doi: 10.1371/journal.ppat.1000204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Stamm CE, Collins AC, Shiloh MU. 2015. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev 264:204–219. doi: 10.1111/imr.12263 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Basu J, Shin DM, Jo EK. 2012. Mycobacterial signaling through toll-like receptors. Front Cell Infect Microbiol 2:145. doi: 10.3389/fcimb.2012.00145 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Jani C, Solomon SL, Peters JM, Pringle SC, Hinman AE, Boucau J, Bryson BD, Barczak AK, Barrett KE. 2023. TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in Macrophages and in vivo. mSystems:e0005223. doi: 10.1128/msystems.00052-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Stanley SA, Johndrow JE, Manzanillo P, Cox JS. 2007. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 178:3143–3152. doi: 10.4049/jimmunol.178.5.3143 [DOI] [PubMed] [Google Scholar]
- 13. Lienard J, Movert E, Valfridsson C, Sturegård E, Carlsson F. 2016. ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNgamma-mediated autophagy and growth restriction of intracellular mycobacteria. Cell Microbiol 18:1471–1485. doi: 10.1111/cmi.12594 [DOI] [PubMed] [Google Scholar]
- 14. Watson RO, Bell SL, MacDuff DA, Kimmey JM, Diner EJ, Olivas J, Vance RE, Stallings CL, Virgin HW, Cox JS. 2015. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce Type I Interferons and activate Autophagy. Cell Host Microbe 17:811–819. doi: 10.1016/j.chom.2015.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lienard J, Nobs E, Lovins V, Movert E, Valfridsson C, Carlsson F. 2020. The Mycobacterium Marinum ESX-1 system mediatesphagosomal permeabilization and type I interferon production via separable mechanisms. Proc Natl Acad Sci U S A 117:1160–1166. doi: 10.1073/pnas.1911646117 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Blanc L, Gilleron M, Prandi J, Song O-R, Jang M-S, Gicquel B, Drocourt D, Neyrolles O, Brodin P, Tiraby G, Vercellone A, Nigou J. 2017. Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. Proc Natl Acad Sci U S A 114:11205–11210. doi: 10.1073/pnas.1707840114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS. 2007. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110:3234–3244. doi: 10.1182/blood-2007-03-079152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Gopalakrishnan A, Salgame P. 2016. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question. Curr Opin Immunol 42:76–82. doi: 10.1016/j.coi.2016.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Hu W, Spaink HP. 2022. The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target. Biology (Basel) 11:246. doi: 10.3390/biology11020246 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Hölscher C, Reiling N, Schaible UE, Hölscher A, Bathmann C, Korbel D, Lenz I, Sonntag T, Kröger S, Akira S, Mossmann H, Kirschning CJ, Wagner H, Freudenberg M, Ehlers S. 2008. Containment of Aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. Eur J Immunol 38:680–694. doi: 10.1002/eji.200736458 [DOI] [PubMed] [Google Scholar]
- 21. Drennan MB, Nicolle D, Quesniaux VJF, Jacobs M, Allie N, Mpagi J, Frémond C, Wagner H, Kirschning C, Ryffel B. 2004. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 164:49–57. doi: 10.1016/S0002-9440(10)63095-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Yoshida A, Inagawa H, Kohchi C, Nishizawa T, Soma G-I. 2009. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes. Anticancer Res 29:907–910. [PubMed] [Google Scholar]
- 23. Netea MG, Van der Meer JWM, Kullberg B-J. 2004. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 12:484–488. doi: 10.1016/j.tim.2004.09.004 [DOI] [PubMed] [Google Scholar]
- 24. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167:910–918. doi: 10.4049/jimmunol.167.2.910 [DOI] [PubMed] [Google Scholar]
- 25. El-Masry EA, Taher I, Hetta HF, Eldahdouh SS. 2022. Pulmonary tuberculosis susceptibility and association with toll-like receptor 2 Arg753Gln polymorphism. J Infect Dev Ctries 16:125–133. doi: 10.3855/jidc.14885 [DOI] [PubMed] [Google Scholar]
- 26. Pattabiraman G, Panchal R, Medvedev AE. 2017. The R753Q polymorphism in toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs Myd88 adapter recruitment to TLR2. J Biol Chem 292:10685–10695. doi: 10.1074/jbc.M117.784470 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Hu L, Tao H, Tao X, Tang X, Xu C. 2019. TLR2 Arg753Gln gene polymorphism associated with tuberculosis susceptibility: an updated meta-analysis. Biomed Res Int 2019:2628101. doi: 10.1155/2019/2628101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Thuong NTT, Hawn TR, Thwaites GE, Chau TTH, Lan NTN, Quy HT, Hieu NT, Aderem A, Hien TT, Farrar JJ, Dunstan SJ. 2007. A polymorphism in human TLRlr2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 8:422–428. doi: 10.1038/sj.gene.6364405 [DOI] [PubMed] [Google Scholar]
- 29. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773. doi: 10.1126/science.1123933 [DOI] [PubMed] [Google Scholar]
- 30. Correa-Macedo W, Cambri G, Schurr E. 2019. The interplay of human and Mycobacterium tuberculosis genomic variability. Front Genet 10:865. doi: 10.3389/fgene.2019.00865 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Pisu D, Huang L, Grenier JK, Russell DG. 2020. Dual RNA-Seq of Mtb-infected Macrophages in vivo reveals ontologically distinct host-pathogen interactions. Cell Rep 30:335–350. doi: 10.1016/j.celrep.2019.12.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Chung ES, Johnson WC, Aldridge BB. 2022. Types and functions of heterogeneity in mycobacteria. Nat Rev Microbiol 20:529–541. doi: 10.1038/s41579-022-00721-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Geraldes I, Fernandes M, Fraga AG, Osório NS. 2022. The impact of single-cell genomics on the field of mycobacterial infection. Front Microbiol 13:989464. doi: 10.3389/fmicb.2022.989464 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Esaulova E, Das S, Singh DK, Choreño-Parra JA, Swain A, Arthur L, Rangel-Moreno J, Ahmed M, Singh B, Gupta A, Fernández-López LA, de la Luz Garcia-Hernandez M, Bucsan A, Moodley C, Mehra S, García-Latorre E, Zuniga J, Atkinson J, Kaushal D, Artyomov MN, Khader SA. 2021. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29:165–178. doi: 10.1016/j.chom.2020.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Pisu D, Huang L, Narang V, Theriault M, Lê-Bury G, Lee B, Lakudzala AE, Mzinza DT, Mhango DV, Mitini-Nkhoma SC, Jambo KC, Singhal A, Mwandumba HC, Russell DG. 2021. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med 218:e20210615. doi: 10.1084/jem.20210615 [DOI] [PMC free article] [PubMed] [Google Scholar]
